Nesivine Eucalyptus (Oxymetazoline Hydrochloride)

Oxymetazoline Hydrochloride, the active ingredient in Nesivine Eucalyptus, is a alpha-adrenergic agonist presented as a nasal spray for topical nasal use. It provides temporary relief of nasal congestion caused by colds, sinusitis, and allergic rhinitis in adults and children when appropriate.

GNH USA supplies Nesivine Eucalyptus as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxymetazoline Hydrochloride acts on the nasal mucosa to relieve congestion associated with upper‑respiratory conditions. - Common cold nasal congestion: reduces swelling of nasal passages for quicker breathing. - Acute sinusitis: eases blockage of sinus ostia, improving drainage and comfort. - Allergic rhinitis: diminishes nasal swelling caused by allergen exposure, allowing normal airflow.

Adverse reactions may occur with nasal administration of oxymetazoline.

Common Side Effects: - Nasal irritation or burning sensation: mild discomfort at the site of application. - Dryness of nasal mucosa: reduced moisture leading to crusting. - Sneezing: transient reflex response. - Headache: mild tension type. - Bitter or metallic taste: after spray contact with the throat. - Epistaxis (nosebleed): occasional minor bleeding.

Serious or Rare Side Effects: - Rebound congestion (rhinitis medicamentosa): worsening blockage after prolonged use. - Hypertension: elevated blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heart rhythm in patients with pre‑existing conditions. - Severe allergic reaction (anaphylaxis): rare but requires immediate medical attention.

Before using Nesivine Eucalyptus, consider the following safety measures. - Use in children under 6 years: not recommended unless directed by a healthcare professional. - Pregnancy: safety not established; consult a physician before use. - Breastfeeding: discuss potential risks with a medical provider. - Concurrent MAO inhibitor therapy: avoid use due to possible hypertensive crisis. - Patients with hypertension: monitor blood pressure closely during treatment. - Store at room temperature: keep in the original container, protect from moisture and heat.

Oxymetazoline may interact with other medications that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension. - Sympathomimetic drugs (e.g., ephedrine): additive vasoconstrictive effect. - Tricyclic antidepressants: may potentiate cardiovascular effects.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood‑pressure‑lowering efficacy. - Other nasal decongestants: increased risk of rebound congestion and systemic side effects.